Adicet Bio, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Adicet Bio, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 3.6 times its market value (net cash). Higher than 98% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-38.4×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 68% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -42%In 3 years sales changed by -100% while total assets changed by -42%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-29.9×Operating cash was negative last year, while some debt falls due within a year.
Lower than 63% of Healthcare companies in United States.
Cash Cushion Ratio
3.6× cashCash, after subtracting all debt, is 3.6 times its market value (net cash).
Higher than 98% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Adicet Bio, Inc. made a loss over the last year. Adicet Bio, Inc. owes $0.19 for every $1 it owns. Adicet Bio, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAdicet Bio, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.31The share price is 0.31 times Adicet Bio, Inc.'s book value per share, lower than 96% of Healthcare companies in United States.
Market cap
$37 MThe total market value of all of Adicet Bio, Inc.'s shares at today's price (share price × number of shares), smaller than 77% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$120 MWhat Adicet Bio, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$12.83Net worth divided by the number of shares. The share price of $3.99 is 0.3 times this, which is the P/B above.
Return on equity (ROE)
-78.1%Adicet Bio, Inc. lost 78.1% of its shareholders' money over the last year, lower than 64% of Healthcare companies in United States.
Owes vs Owns
0.19×Adicet Bio, Inc. owes $0.19 for every $1 it owns (low), lower than 74% of Healthcare companies in United States.
Dividend yield
NoneAdicet Bio, Inc. does not currently pay a dividend.
Profit growth
LossAdicet Bio, Inc. made a loss in each of the last two years.
Interest cover
Not coveredAdicet Bio, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashAdicet Bio, Inc. held $144 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Adicet Bio, Inc.: $37 M ÷ $120 M (30 Jun 2026) = 0.3.
What is Adicet Bio, Inc.'s return on equity?
Adicet Bio, Inc. lost 78.1% of its shareholders' money over the last year, lower than 64% of Healthcare companies in United States.
How much does Adicet Bio, Inc. owe compared with what it owns?
Adicet Bio, Inc. owes $0.19 for every $1 it owns (low), lower than 74% of Healthcare companies in United States.
Does Adicet Bio, Inc. pay a dividend?
No. Adicet Bio, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.